Dimethylaminoparthenolide reduces the incidence of dysplasia and ameliorates a wasting syndrome in HPV16-transgenic mice.
Santos JMO, Moreira-Pais A, Neto T, Peixoto da Silva S, Oliveira PA, Ferreira R, Mendes J, Bastos MMSM, Lopes C, Casaca F, Silva S, Sweeney C, Medeiros R, Gil da Costa RM.
Santos JMO, et al. Among authors: peixoto da silva s.
Drug Dev Res. 2019 Sep;80(6):824-830. doi: 10.1002/ddr.21565. Epub 2019 Jul 13.
Drug Dev Res. 2019.
PMID: 31301186